Article Information
History
- December 5, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Desiré Casares-Marfil1,
- Manuel Martínez-Bueno2,
- Maria Orietta Borghi3,
- Guillermo Pons-Estel4,
- PRECISESADS Clinical Consortium,
- Guillermo Reales5,
- Yu Zuo6,
- Gerard Espinosa4,
- Timothy Radstake7,
- Lucas L. van den Hoogen8,
- Chris Wallace9,
- Joel Guthridge10,
- Judith A James10,
- Ricard Cervera4,
- Pier Luigi Meroni11,
- Javier Martin12,
- Jason S. Knight6,
- Marta E. Alarcón-Riquelme2,* and
- Amr H. Sawalha13,*,#
- 1Division of Rheumatology, Department of Pediatrics, University of Pittsburgh, Pittsburgh, USA;
- 2Genetics of Complex Diseases Group, Department of Genomic Medicine, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain;
- 3Division of Rheumatology, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Immunorheumatology research laboratory – IRCCS Istituto Auxologico Italiano, Milan, Italy;
- 4Department of Autoimmune Diseases, Reference Centre for Systemic Autoimmune Diseases (UEC/CSUR) of the Catalan and Spanish Health Systems-Member of ERN-ReCONNET, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain;
- 5Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Puddicombe Way, Cambridge CB2 0AW, UK; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK;
- 6Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA;
- 7Laboratory for Translational Immunology and Department of Pediatric Rheumatology and Immunology, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands;
- 8Department of Rheumatology, Radboudumc and Sint Maartenskliniek, Nijmegen, The Netherlands;
- 9Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Puddicombe Way, Cambridge CB2 0AW, UK; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK; MRC Biostatistics Unit, University of Cambridge, Cambridge Institute of Public Health, Forvie Site, Robinson Way, Cambridge Biomedical Campus, Cambridge CB2 0SR, UK;
- 10Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA;
- 11Immunorheumatology research laboratory – IRCCS Istituto Auxologico Italiano, Milan, Italy;
- 12Institute of Parasitology and Biomedicine “López-Neyra”, CSIC, Granada, Spain;
- 13Departments of Pediatrics, Medicine, and Immunology & Lupus Center of Excellence, University of Pittsburgh, Pittsburgh, USA
- ↵#Please address correspondence to Amr H. Sawalha, MD. Address: 7123 Rangos Research Center, 4401 Penn Avenue, Pittsburgh, PA 15224, USA. Phone: (412) 692-8140. Fax: (412) 412-692-5054. Email: asawalha{at}pitt.edu Conflict of interest:
None of the authors has any financial conflict of interest to disclose. Dr. Chris Wallace is partially funded by GSK and MSD, and holds a part time position at GSK. Neither funder had any involvement with or influence on this work.
↵* These two authors equality contributed to this work.
Posted December 05, 2023.
A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome
